ACE and diabetes mellitus: These patients tend to suffer from poorly controlled hypertension (HTN) and diabetes (DM) with low rates of statins, angiotensin converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARB) use despite their high cardiovascular risk.